Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs

BACKGROUND: Decisions relating to the funding of new drugs are becoming increasingly challenging due to a combination of aging populations, rapidly increasing list prices, and greater numbers of drug-indication pairs being brought to market. This is especially true in cancer, where rapid list price...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Public Health
Asıl Yazarlar: Costa, Sarah, Bentley, Colene, Regier, Dean A., McTaggart-Cowan, Helen, Mitton, Craig, Burgess, Michael M., Peacock, Stuart J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6647147/
https://ncbi.nlm.nih.gov/pubmed/31331312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-019-7303-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller